Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2020 09:00 ET | Source: Nobilis Therapeutics, Inc.

Nobilis Therapeutics to Present at CapCon 2020 Venture Conference

PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will...
February 23, 2018 15:19 ET | Source: Nobilis Therapeutics, Inc.

Nobilis Therapeutics Presents Its PTSD Clinical Development Program To The US Congress

WASHINGTON, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Dr. Edward Meloni, PhD of McLean Hospital (Harvard Medical School Affiliate) and Dr. Vlad Bogin, CEO and Founder of Nobilis Therapeutics earlier this...
June 14, 2017 13:34 ET | Source: Nobilis Therapeutics, Inc.

Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder

PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...
June 12, 2017 18:57 ET | Source: Nobilis Therapeutics, Inc.

Nobilis Therapeutics Receives a Notice of Allowance for a Patent Covering Treatment of Psychiatric Disorders With Noble Gases

PORTLAND, Ore., June 12, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics announced today that the patent that it had exclusively licensed from Partners HealthCare/McLean Hospital (an affiliate of...